Skip to main content
SpringerLink
Log in

Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of this study was to estimate the unit costs of non-vertebral osteoporotic fractures in five European countries based on the results of the SOTI and TROPOS clinical trials in postmenopausal osteoporotic women. The information recorded in the Case Report Forms was used. The perspective of third party payers was adopted. Hip fracture unit cost was the highest. The ranges of costs among countries was narrow for hip from 8,346€ (Italy) to 9,907€ (France), but wider for other fractures: 890€ (Spain) to 2,022€ (Italy) for wrist, 1,167€ (Spain) to 3,268€ (Italy) for pelvis, 837€ (Spain) to 2,116€ (Italy) for sternum/clavicle, 565€ (Spain) to 908€ (France) for rib, 1,518€ (Spain) to 3,651€ (Belgium) for humerus, 1,805€ (Spain) to 3,521€ (Italy) for leg. The costs of those fractures should be considered when estimating the cost of osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Consensus development conference (1993) Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650

    Google Scholar 

  2. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141

    PubMed  CAS  Google Scholar 

  3. Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3–S7

    Article  PubMed  Google Scholar 

  4. Kanis JA, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11(8):669–674

    Article  PubMed  CAS  Google Scholar 

  5. Cooper C, Campion G, Melton LJ III (1992) Hip fractures of the elderly: a worldwide projection. Osteoporos Int Int 2:285–289

    Article  PubMed  CAS  Google Scholar 

  6. Gillet P, Reginster JY (1999) Increased number of hip fractures. Lancet 353:2160–2161

    Article  PubMed  CAS  Google Scholar 

  7. Melton LJ III (1999) Cost-effective treatment strategies for osteoporosis. Osteoporosis Int 9(Suppl 2):S111–S116

    Article  Google Scholar 

  8. Holland E, Rogers L (1989) Osteoporosis: impact on the elderly, sociatal concerns, and the role of radiology. Curr Probl Diagn Radiol 18:46–61

    Article  Google Scholar 

  9. Edy DM, Johnston CC Jr, Cummings SR (1998) Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report. Osteoporos Int 8(Suppl 4):1–88

    Google Scholar 

  10. US Congress Office of Technology Assessment (1994) Hip fracture outcomes in people age 50 and over: background paper. Washington DC/ US Goverment Printing office, July

  11. Johnell O (1997) The socioeconomic burden of fractures: today and in the 21st century. Am J Med 103(2A):20S–25S

    Article  PubMed  CAS  Google Scholar 

  12. Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ 3rd (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13(4):323–330

    Article  PubMed  CAS  Google Scholar 

  13. Meunier PJ, Reginster JY (2003) Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis. Osteoporos Int 14(Suppl 3):S66–S76

    PubMed  CAS  Google Scholar 

  14. Reginster JY, Lecart MP, Deroisy R, Lousberg C (2004) Strontium ranelate: a new paradigm in the treatment of osteoporosis. Expert Opin Investig Drugs 13(7):857–864

    Article  PubMed  CAS  Google Scholar 

  15. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468

    Article  PubMed  CAS  Google Scholar 

  16. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium, ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clinical Endocrinol Metab 90(5):2816–2822

    Article  CAS  Google Scholar 

  17. Data available on the site: http://www.oecd.org/dataoecd/13/12/31963479.xls. Consulted on November 2nd 2005

  18. Lindsay R (1995) The burden of osteoporosis: cost. Am J Med 98(2A):9S–11S

    Article  PubMed  CAS  Google Scholar 

  19. Levy E (1989) Cost analysis of osteoporosis related to untreated menopause. Clin Rheumatol 8(Suppl 2):76–82

    Article  PubMed  Google Scholar 

  20. Jönsson B, Christiansen C, Johnell O, Hedbrandt J (1995) Cost-effectiveness of fracture prevention in established osteoporosis. Osteoporos Int 5(2):136–142

    Article  PubMed  Google Scholar 

  21. Kakarlapudi TK, Santini A, Shahane SA, Douglas D (2000) The cost of treatment of distal radial fractures. Injury 31(4):229–232

    Article  PubMed  CAS  Google Scholar 

  22. French FH, Torgerson DJ, Porter RW (1995) Cost analysis of fracture of the neck of femur. Age Ageing 24(3):185–189

    Article  PubMed  CAS  Google Scholar 

  23. Reginster JY, Gillet P, Ben Sedrine W, Brands G, Ethgen O, De Froimont C, Gosset C (1999) Direct costs of hip fractures in patients over 60 years of age in Belgium. Pharmacoeconomics 15(5):507–514

    Article  PubMed  CAS  Google Scholar 

  24. Parker MJ, Myles JW, Pryor GA, Lodwick R (1991) Cost analysis of different aspects of treatment of patients following fracture of the proximal femur. J Bone Joint Surg Br 73B:70

    Google Scholar 

  25. Visentin P, Ciravegna R, Fabris F (1997) Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy. Maturitas 26(3):185–192

    Article  PubMed  CAS  Google Scholar 

  26. Hollingworth W, Todd CJ, Parker MJ (1996) The cost of treating hip fractures in the twenty-first century: short report. Osteoporos Int 6(Suppl 2):13–15

    Article  PubMed  Google Scholar 

  27. Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8(6):611–617

    Article  PubMed  CAS  Google Scholar 

  28. Schurch MA, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour JP (1996) A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 11(12):1935–1942

    Article  PubMed  CAS  Google Scholar 

  29. Koeck CM, Schwappach DL, Niemann FM, Strassmann TJ, Ebner H, Klaushofer K (2001) Incidence and costs of osteoporosis-associated hip fractures in Austria. Wien Klin Wochenschr 113(10):371–377

    PubMed  CAS  Google Scholar 

  30. Ankjaer-Jensen A, Johnell O (1996) Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments. Osteoporos Int 6:265–275

    Article  PubMed  CAS  Google Scholar 

  31. Borgquist L, Lindelöw G, Thorngren KG (1991) Costs of hip fracture. Rehabilitation of 180 patients in primary health care. Acta Orthop Scand 62:39–48

    Article  PubMed  Google Scholar 

  32. Koeck CM, Schwappach DL, Niemann FM, Strassmann TJ, Ebner H, Klaushofer K (2001) Incidence and costs of osteoporosis-associated hip fractures in Austria. Wien Klin Wochenschr 113(10):371–377

    PubMed  CAS  Google Scholar 

  33. Brecht JG, Kruse HP, Felsenberg D, Mohrke W, Oestreich A, Huppertz E (2003) Pharmacoeconomic analysis of osteoporosis treatment with risedronate. Int J Clin Pharmacol Res 23(4):93–105

    PubMed  CAS  Google Scholar 

  34. Haentjens P, Autier P, Barette M, Boonen S; Belgian Hip Fracture Study Group (2001) The economic cost of hip fractures among elderly women. A one-year, prospective, observational cohort study with matched-pair analysis. Belgian Hip Fracture Study Group. J Bone Joint Surg Am 83-A(4):493–500

    Google Scholar 

  35. Nurmi I, Narinen A, Luthje P, Tanninen S (2003) Cost analysis of hip fracture treatment among the elderly for the public health services: a 1-year prospective study in 106 consecutive patients. Arch Orthop Trauma Surg 123(10):551–554

    Article  PubMed  Google Scholar 

  36. De Laet CE, van Hout BA, Burger H, Weel AE, Hofman A, Pols HA (1999) Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study. Osteoporos Int 10(1):66–72

    Article  PubMed  Google Scholar 

  37. Sernbo I, Johnell O (1993) Consequences of hip fracture: a prospective study over 1 year. Osteoporosis Int 3:148–153

    Article  CAS  Google Scholar 

  38. Zethraeus N, Gerdtham UG (1998) Estimating the costs of hip fracture and potential savings. Int J Technol Assess Health Care 14(2):255–267

    Article  PubMed  CAS  Google Scholar 

  39. Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 6(29):1–146

    PubMed  CAS  Google Scholar 

  40. Chamberlin B, Benazet JP, Humbert B, Saillant G (1999) Direct cost assessment of wrist fractures. Rev Chir Orthop Reparatrice Appar Mot 85(8):828–833

    PubMed  CAS  Google Scholar 

  41. Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR (1991) Which fractures are associated with low appendicular bone mass in the elderly women? The Study of Osteoporotic Fractures Research Group. Ann Intern Med 115:837–842

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study has been granted by the Servier Laboratories.

Author information

Authors and Affiliations

  1. CEMKA, 43 boulevard du Maréchal Joffre, 92340, Bourg La Reine, France

    S. Bouee, A. Lafuma & F. Fagnani

  2. Hôpital Edouard Herriot, 5 place Arsonval, 69437, Lyon cedex 03, France

    P. J. Meunier

  3. Centre Universitaire d’Investigation du Metabolisme Osseux et du Cartilage Articulaire, University of Liege, place du 20 août, 4000, Liege, Belgium

    J. Y. Reginster

Authors
  1. S. Bouee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Lafuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Fagnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. J. Meunier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Y. Reginster
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Bouee.

Additional information

Conflict of Interest: Professors Meunier and Reginster have received fees from Servier for their support as consultant for the research conducted by Servier.

This is the first published study estimating the cost of osteoporotic fractures other than vertebral, hip and wrist. The estimates are based on data collected in two clinical trials and might concern a selected subgroup of women meeting the inclusion criteria.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bouee, S., Lafuma, A., Fagnani, F. et al. Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int 26, 1063–1072 (2006). https://doi.org/10.1007/s00296-006-0180-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-006-0180-x

Keywords

Search

Navigation